NASDAQ:BLUE
bluebird bio Stock News
$1.03
-0.0200 (-1.90%)
At Close: May 17, 2024
Celyad devient Celyad Oncology
12:00am, Wednesday, 10'th Jun 2020
Regulatory News: Celyad SA (Euronext & Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), une société biotechnologique de stade clinique fo
Here is What Hedge Funds Think About bluebird bio Inc (BLUE)
05:25am, Monday, 08'th Jun 2020
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investmen
Here is What Hedge Funds Think About bluebird bio Inc (BLUE)
11:21am, Sunday, 07'th Jun 2020
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investmen
The Week Ahead In Biotech: Viela FDA Decision, Hematology Conference Take Center Stage
12:00am, Sunday, 07'th Jun 2020
The biotech space saw a flurry of activity last week, with coronavirus-related news, conference presentations and IPOs.
Negative clinical readouts led to some strong selling in...
Jack Monroe: Sometimes even I don't want to go into the kitchen says cook
01:00am, Saturday, 06'th Jun 2020
WHY is it that when we say 'comfort food', we think of 'treats' to indulge in every once in a while, or worse still, attach feelings of guilt or shame to comforting ourselves with food? Some days, you
bluebird bio's Shares March Higher, Can It Continue?
09:35am, Friday, 05'th Jun 2020
As of late, it has definitely been a great time to be an investor in bluebird bio.
Pliant Therapeutics Shares Have Climbed 44% Since This Week's IPO
08:01pm, Thursday, 04'th Jun 2020
Several other biotechs lined up to go public as life sciences companies gain higher profiles due to fight against the coronavirus Continue reading...
bluebird bio Announces That Its 2020 Annual Meeting of Stockholders Will Be Held in Virtual Format
08:05pm, Wednesday, 03'rd Jun 2020
bluebird bio, Inc. (NASDAQ: BLUE) today announced that, due to the public health and safety concerns related to the novel coronavirus (COVID-19) pandemic, to support the health and well-being of its d
Global Sickle Cell Disease Clinical Trial Pipeline Highlights 2020 - ResearchAndMarkets.com
12:00am, Friday, 29'th May 2020
The
Morgan Stanley Maintains Equal-Weight on bluebird bio, Raises Price Target to $73
12:05pm, Thursday, 28'th May 2020bluebird bio Announces Live Webcast of EHA Data Review and June Investor Events
12:00pm, Thursday, 28'th May 2020
bluebird bio, Inc. (NASDAQ: BLUE) today announced that the company will host a live webcast to review new data presented at the European Hematology Association (EHA) Annual Meeting on Friday, June 12
SVB Leerink Maintains Outperform on bluebird bio, Raises Price Target to $129
10:55am, Thursday, 28'th May 2020Foresite Capital Management IV, LLC Buys Biohaven Pharmaceutical Holding Co, bluebird bio Inc, ...
12:00am, Thursday, 28'th May 2020What Sanofi Might Buy With Its Regeneron Windfall
02:35pm, Wednesday, 27'th May 2020
The drug company has not said what it plans to do with the cash, but analysts speculate that it will pursue a gene therapy company worth around $5 billion.
Bristol-Myers Analyst Says 'Big 7' Pipeline Assets Hold $15B In Peak Sales Potential
12:00am, Wednesday, 27'th May 2020
Biopharma companies are among the most resilient among sectors during the coronavirus pandemic, and one large-cap biopharma has a slew of products in its pipeline that have...
